OSCR

Subanesthetic doses of ketamine to rats and monkeys rapidly increases radioligand binding in brain to phosphodiesterase-4, an indirect marker of cAMP.

Overview

Authors: Paul A Parcon1, Amanda Bardhoshi1, Amanda Olsen-Dufour1, Raven Cureton1, Susovan Jana1, Cheryl L Morse1, Ioline D Henter1, Julia Totis1, Adrian E Jenson1, Matilah T Pamie-George1, Jeih-San Liow1, Sami S Zoghbi1, Shawn Wu1, Victor W Pike1, Robert B Innis1
  1. Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD USA
Institutions: National Institutes of Health (United States); National Institute of Mental Health (United States)
Journal: Translational psychiatry, volume 16, issue 1, article 297
Dates: received 26 September 2025; accepted 9 April 2026; published online 21 April 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1038/s41398-026-04039-w · PMID 42014381 · PMCID PMC13233975 · OpenAlex W7155037433
Open access: gold, a free copy (OpenAlex)
Categories: PET / SPECT (modality), rat (organism), non-human primate (organism), depression (population), clinical / translational (subfield)
Methods: Statistics
Keywords: Biomarkers, Neuroscience, Depression
MeSH: Antidepressive Agents*, Brain*, Cyclic AMP*, Cyclic Nucleotide Phosphodiesterases, Type 4*, Ketamine*, Animals, Carbon Radioisotopes, Macaca mulatta, Male, Phosphodiesterase 4 Inhibitors, Positron-Emission Tomography, Pyrazoles, Pyridazines, Rats, Rats, Sprague-Dawley, Rolipram (* major topic)
Topic: Phosphodiesterase function and regulation (Molecular Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Funding: U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) (ZIAMH002793, ZIAMH002852)
Citations: not cited yet (Europe PMC); 31 references in the paper

Abstract

The N-methyl-D-aspartate (NMDA) receptor antagonist ketamine is a robust, rapid-acting antidepressant whose molecular effects have not been fully elucidated. Phosphodiesterase-4 (PDE4), which terminates cyclic adenosine monophosphate (cAMP) activity, may underlie antidepressant response. In particular, previous studies found that whole brain binding of the positron emission tomography (PET) radioligand [11C](R)-rolipram to PDE4 was decreased in individuals with major depressive disorder; eight weeks of antidepressant treatment rescued this decrease in [11C](R)-rolipram binding. This study used [11C](R)-rolipram, which targets all PDE4 subtypes, and [18F]PF-06445974, which is preferential for PDE4B over PDE4D, to determine whether ketamine infusion could rapidly increase cAMP activity in rats (at 10 mg/kg) and rhesus macaques (at 0.5 mg/kg). Ketamine increased [11C](R)-rolipram binding to PDE4 in rats (mean standardized uptake value (SUV) increase=24% ± 14%, range=3%-42%, p = 0.004) and in monkeys (mean distribution volume (VT) increase=14% ± 2%, range=12%-16%, p = 0.003). Ketamine also increased [18F]PF-06445974 binding in monkeys within one hour of infusion (mean VT increase 28% ± 7%, range=16%-37%, p = 0.008). When [11C](S)-rolipram, which has no specific binding to PDE4, was used to control for the effects of ketamine on blood flow and radioligand delivery in rats, no consistent effects were observed for ketamine. Collectively, the results suggest that ketamine infusion rapidly increases cAMP activity and may be an underlying mechanism for ketamine’s rapid antidepressant effects. These data support a common pathway for cAMP and antidepressant action and suggest that PDE4 inhibition, particularly PDE4B, may be an effective and rapid-acting antidepressant mechanism.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability

The data that support the findings of this study are available on OpenNeuro (https://openneuro.org/datasets/ds007653).

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 29 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 15 authors, 3 keywords, 16 MeSH terms, 1 funder, 30 references.

Cite

This paper

Parcon, P. A., Bardhoshi, A., Olsen-Dufour, A., Cureton, R., Jana, S., Morse, C. L., Henter, I. D., Totis, J., Jenson, A. E., Pamie-George, M. T., Liow, J.-S., Zoghbi, S. S., Wu, S., Pike, V. W., & Innis, R. B. (2026). Subanesthetic doses of ketamine to rats and monkeys rapidly increases radioligand binding in brain to phosphodiesterase-4, an indirect marker of cAMP. Translational psychiatry, 16(1), 297. https://doi.org/10.1038/s41398-026-04039-w

BibTeX

@article{parcon2026subanesthetic,
author = {Parcon, Paul A and Bardhoshi, Amanda and Olsen-Dufour, Amanda and Cureton, Raven and Jana, Susovan and Morse, Cheryl L and Henter, Ioline D and Totis, Julia and Jenson, Adrian E and Pamie-George, Matilah T and Liow, Jeih-San and Zoghbi, Sami S and Wu, Shawn and Pike, Victor W and Innis, Robert B},
title = {{Subanesthetic doses of ketamine to rats and monkeys rapidly increases radioligand binding in brain to phosphodiesterase-4, an indirect marker of cAMP}},
journal = {Translational psychiatry},
year = {2026},
month = apr,
volume = {16},
number = {1},
pages = {297},
publisher = {Nature Publishing Group},
issn = {2158-3188},
doi = {10.1038/s41398-026-04039-w},
url = {https://doi.org/10.1038/s41398-026-04039-w},
pmid = {42014381},
pmcid = {PMC13233975}
}

RIS

TY - JOUR
AU - Parcon, Paul A
AU - Bardhoshi, Amanda
AU - Olsen-Dufour, Amanda
AU - Cureton, Raven
AU - Jana, Susovan
AU - Morse, Cheryl L
AU - Henter, Ioline D
AU - Totis, Julia
AU - Jenson, Adrian E
AU - Pamie-George, Matilah T
AU - Liow, Jeih-San
AU - Zoghbi, Sami S
AU - Wu, Shawn
AU - Pike, Victor W
AU - Innis, Robert B
TI - Subanesthetic doses of ketamine to rats and monkeys rapidly increases radioligand binding in brain to phosphodiesterase-4, an indirect marker of cAMP
T2 - Translational psychiatry
J2 - Transl Psychiatry
PY - 2026
DA - 2026/04/21
VL - 16
IS - 1
SP - 297
SN - 2158-3188
PB - Nature Publishing Group
DO - 10.1038/s41398-026-04039-w
UR - https://doi.org/10.1038/s41398-026-04039-w
LA - en
ER -

CSL-JSON

{
"id": "10.1038/s41398-026-04039-w",
"type": "article-journal",
"title": "Subanesthetic doses of ketamine to rats and monkeys rapidly increases radioligand binding in brain to phosphodiesterase-4, an indirect marker of cAMP",
"container-title": "Translational psychiatry",
"author": [
{
"family": "Parcon",
"given": "Paul A"
},
{
"family": "Bardhoshi",
"given": "Amanda"
},
{
"family": "Olsen-Dufour",
"given": "Amanda"
},
{
"family": "Cureton",
"given": "Raven"
},
{
"family": "Jana",
"given": "Susovan"
},
{
"family": "Morse",
"given": "Cheryl L"
},
{
"family": "Henter",
"given": "Ioline D"
},
{
"family": "Totis",
"given": "Julia"
},
{
"family": "Jenson",
"given": "Adrian E"
},
{
"family": "Pamie-George",
"given": "Matilah T"
},
{
"family": "Liow",
"given": "Jeih-San"
},
{
"family": "Zoghbi",
"given": "Sami S"
},
{
"family": "Wu",
"given": "Shawn"
},
{
"family": "Pike",
"given": "Victor W"
},
{
"family": "Innis",
"given": "Robert B"
}
],
"container-title-short": "Transl Psychiatry",
"volume": "16",
"issue": "1",
"page": "297",
"DOI": "10.1038/s41398-026-04039-w",
"PMID": "42014381",
"PMCID": "PMC13233975",
"ISSN": "2158-3188",
"publisher": "Nature Publishing Group",
"URL": "https://doi.org/10.1038/s41398-026-04039-w",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
21
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41398-025-03724-6
Response of iPSC-derived neurons from individuals with treatment-resistant depression to (2 R,6 R)-hydroxynorketamine and reelin: an exploratory study.
Journal: Translational psychiatry
In common: depression, 3 references
[2] doi:10.3390/molecules30030692
Molecular Properties of Phosphodiesterase 4 and Its Inhibition by Roflumilast and Cilomilast.
Journal: Molecules (Basel, Switzerland)
In common: 2 references
[3] doi:10.1093/braincomms/fcag136 [code]
Lower synaptic density in mood circuitry underlies depression in Parkinson's disease.
Journal: Brain communications
In common: PET / SPECT, depression, 1 reference
[4] doi:10.1038/s41380-024-02419-6 [code]
(R)-ketamine restores anterior insular cortex activity and cognitive deficits in social isolation-reared mice.
Journal: Molecular psychiatry
In common: 2 references
[5] doi:10.1038/s41380-026-03527-1
NADPH oxidase-1 suppression prolongs the antidepressant-like effect of ketamine.
Journal: Molecular psychiatry
In common: depression, rat, 1 reference
[6] doi:10.1073/pnas.2510642122 [code]
Spontaneous glutamate release activates mGluR signaling to drive rapid antidepressant responses.
Journal: Proceedings of the National Academy of Sciences of the United States of America
In common: depression, rat, 1 reference
[7] doi:10.1080/21655979.2021.2005744
<i>Xiaoyao</i> powder alleviates the hippocampal neuron damage in chronic unpredictable mild stress-induced depression model rats in hippocampus via connexin 43Cx43/glucocorticoid receptor/brain-derived neurotrophic factor signaling pathway.
Journal: Bioengineered
In common: depression, rat, 1 reference
[8] doi:10.1038/s41398-024-02837-8 [code]
Preliminary evidence for preserved synaptic density in late-life depression.
Journal: Translational psychiatry
In common: PET / SPECT, depression, 1 reference
[9] doi:10.1111/jnc.70502 [code]
The Converging Effects of Different Categories of Antidepressants on the Brain: A Systematic Meta-Analysis of Public Transcriptional Profiling Data From the Hippocampus and Cortex.
Journal: Journal of neurochemistry
In common: depression, rat, 1 reference
[10] doi:10.3389/fphar.2026.1895800
NDP-MSH rescues LPS-induced neuroinflammation, synaptic deficits, and depressive-like behaviors in mice: involvement of MC1R-cAMP/PKA signaling.
Journal: Frontiers in pharmacology
In common: depression, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.